Functionalized Cyclopentenones with Low Electrophilic Character as Anticancer Agents

Author:

Andrade Késsia H. S.1,Coelho Jaime A. S.2,Frade Raquel1,Madureira Ana M.1,Nunes João P. M.34,Caddick Stephen4,Gomes Rafael F. A.15ORCID,Afonso Carlos A. M.1

Affiliation:

1. Research Institute for Medicines (iMed.ULisboa) Faculty of Pharmacy Universidade de Lisboa 1649-003 Lisboa Portugal

2. Centro de Química Estrutural Institute of Molecular Sciences Faculty of Sciences University of Lisbon 1749-016 Lisboa Portugal

3. Abzena Ltd. Babraham Research Campus Cambridge CB22 3AT UK

4. Department of Chemistry University College London London WC1H 0AJ UK

5. CBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies Universidade Lusófona, Lisboa 1749-024 Lisboa Portugal

Abstract

AbstractIn this study were synthesized non‐Michael acceptor cyclopentenones (CP) from biomass derivative furfural as anticancer agents. Cyclic enones, both from natural sources and synthetic analogues, have been described as cytotoxic agents. Most of these agents were unsuccessful in becoming valuable therapeutic agents due to toxicity problems derived from unselective critical biomacromolecule alkylation. This may be caused by Michael addition to the enone system. Ab initio studies revealed that 2,4‐substituted CPs are less prone to Michael additions, and as such were tested three families of those derivatives. We prepare the new CPs from furfural through a tandem furan ring opening/Nazarov electrocyclization and further functionalization. Experimentally the 2,4‐substituted CPs exhibited no reactivity towards sulphur nucleophiles, while maintaining cytotoxicity against HT‐29, MCF‐7, NCI‐H460, HCT‐116 and MDA‐MB 231 cells lines. Moreover, the selected CP are non‐toxic against healthy HEK 293T cell lines and present proper calculated drug‐like properties.

Funder

Fundação para a Ciência e a Tecnologia

HORIZON EUROPE Widening Participation and Strengthening the European Research Area

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3